Navigation Links
Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
Date:2/26/2008

sed patients, such as those with HIV-AIDS or undergoing bone marrow transplantation. Given this lead, Lixte is initiating studies to assess the potential value of these compounds for treatment of serious fungal diseases."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. (Lixte) is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers. Over the past year, based on the discovery of a new biomarker for brain cancers by collaborators at NIH, the company is working with NINDS, NIH to develop more effective treatments for glioblastoma multiforme (GBM), the most common and most aggressive type of primary brain cancer in adults and other brain cancers of adults and children.

GBM occurs annually in 20,000 to 25,000 adults in the United States and in a comparable number of individuals in Europe. At present, there is no curative treatment known for this disease. Standard treatment involves surgery, radiation and the use of one or more chemotherapeutic agents at the time of initial treatment. At relapse, which occurs in essentially all patients, the present standard treatment is a drug, Temozolomide, which is associated with a modest increase in life span measured in weeks. Thus, there is an urgent need for more effective treatments for GBM.

About the National Institute of Neurological Disorders and Stroke (NINDS), (NIH):

NINDS (http://www.ninds.nih.gov) is a component of the National Institutes of Health (NIH), and is the nation's primary supporter of biomedical research on the brain and nervous system.

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal ag
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Opportunities to Invest in Puerto Rico as Global Center for Biotechnology
2. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
3. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
5. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Biotechnology Builds a New Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Omnicell, Inc ., (Nasdaq: ... system solutions to acute healthcare facilities, today announced ... Health Care Network in Springfield, Missouri, has chosen ... management and supply solutions. ,, "Omnicell,s patient-specific approach ... workflow efficiency, streamline the nurses, access to, distribution ...
(Date:12/17/2009)... Respect for Life" in Majority Leader,s Revisions to ... WASHINGTON, Dec. 17 Americans United for ... letter today to Senate Majority Leader Harry Reid ... Majority Leader,s revisions to a bill - to ... Senator Reid to include "specific language that ensures ...
(Date:12/17/2009)... clothing stores, gas stations -- and adding to obesity epidemic, ... you,re hungry while shopping for a new sofa, don,t despair: ... salty snacks, a new report finds. , In fact, the ... stores to hit most segments of the retail market, say ... the American Journal of Public Health . The ...
(Date:12/17/2009)... outbreak is a good time to get vaccinated, federal ... -- As the current wave of H1N1 swine flu ... that everyone get vaccinated in case another outbreak strikes ... H1N1 flu vaccine have eased, it,s an ideal time ... Secretary Kathleen Sebelius said during a morning press conference. ...
(Date:12/17/2009)... NEW YORK, Dec. 17 Reportlinker.com ... is available in its catalogue: ,, ... designed to provide the animal health industry ... and insight, critical to the development and ... The study,s major objectives include: ,, ...
Breaking Medicine News(10 mins):Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 2Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 3Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 4Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Swine Flu Wanes, But Future Uncertain 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4
... Expert Panel to Discuss Significant Health and Safety Impacts, What Needs ... to Be Done, WASHINGTON, Feb. 25 , ... completed an assessment of the public health workforce shortage -- ... findings and recommended actions., WHY: The ...
... who examined blood test records in a survey of over ... found thousands of cases of probable undiagnosed diabetes. This could ... in UK. , The research is published in the ... was led by Dr Tim Holt of the University of ...
... Billian,s HealthDATA continues to add,new companies ... value of,current subscribers, licenses. In the last ... offering and continues to provide their,customers, with ... have the most current information to guide ...
... ST. PAUL, Minn., Feb. 25 Acuo Technologies, ... the medical imaging,industry for archiving, collaboration and migration ... company achieved 300% growth,over the previous year in ... DICOM Services Grid(TM) software solution; totaling,182 implementations worldwide., ...
... New Enterprise Intelligence Solutions to the Healthcare ... ... 25 HIMSS, Booth #1841 --,Harris Corporation (NYSE: HRS ), ... for healthcare enterprises during the Healthcare,Information and Management Systems Society (HIMSS) ...
... Patient Care with Visibility into Location of Medical Equipment and ... ... Feb. 25 Colubris Networks, the leading,global provider of intelligent wireless ... is working with,AeroScout, Inc., the leading provider of Unified Asset Visibility,solutions, ...
Other Medicine News:Health News:New Assessment Highlights Breadth and Depth of Looming Public Health Workforce Crisis 2Health News:GP's databases could identify tens of thousands with undiagnosed diabetes in UK 2Health News:Billian's HealthDATA(R) Continues to Delight Their Customers with Comprehensive Cutting Edge Healthcare Market Intelligence 2Health News:Billian's HealthDATA(R) Continues to Delight Their Customers with Comprehensive Cutting Edge Healthcare Market Intelligence 3Health News:Acuo Technologies(R) Announces Record Sales and Implementation Growth 2Health News:Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises 2Health News:Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises 3Health News:Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks 2Health News:Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks 3
(Date:12/17/2009)... Connectyx Technologies Holding Group Inc. (Pink Sheets: CTYX) ... partnership with United States Medical Supply, a leading ... and Medications as well as Bladder Control Products ... of the partnership were not disclosed, however Connectyx ... to our growing distribution channel for MedFlash and ...
(Date:12/17/2009)... ANGELES, Dec. 17 Instacare Corp. (OTC ... life-saving and life-enhancing prescription drugs and diagnostics and ... and a leading developer and provider of e-health ... products announced today that as part of the ... has determined to add two new Directors and ...
(Date:12/17/2009)... Pharmaceutical Institute today announced that it has acquired ... in life science courseware. These assets, including ... already extensive library of training resources. ... specialized training solutions for the pharmaceutical and biotech ... Financial terms of the agreement were not disclosed. ...
Breaking Medicine Technology:Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 1NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 2NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 3NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 4NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 5NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 6NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 7NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 8REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 8669 1REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 8669 2Practice Reps Brings Sales and Marketing to the Business of Medical Practice Management 47434 1Practice Reps Brings Sales and Marketing to the Business of Medical Practice Management 47434 2
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
... Our test menu includes kits that quantitatively ... and lipoprotein (a). An elevated serum or ... a strong and independent risk factor for ... early 1970s have associated elevated levels of ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
Medicine Products: